Filtered By:
Specialty: Drugs & Pharmacology
Drug: Coumadin

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 300 results found since Jan 2013.

The impact of percutaneous left atrial appendage closure on left ventricular diastolic function and natriuretic peptide levels
CONCLUSIONS: In the present study, we demonstrated that patients with AF have shown impaired diastolic functions and elevated BNP levels after the percutaneous closure of the LAA.PMID:34919244 | DOI:10.26355/eurrev_202112_27439
Source: Pharmacological Reviews - December 17, 2021 Category: Drugs & Pharmacology Authors: C Şabanoğlu S Okutucu I Halil İnanç H Yorgun K Aytemir A Oto Source Type: research

Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study
ConclusionOverall, the anticoagulation management model developed in this study could be involved in the full process of anticoagulation therapy in AF patients to improve rationality, adherence, and satisfaction in both medical professionals and patients. However, the usability, feasibility, and acceptability of the I-Anticoagulant-based anticoagulation management model need to be further assessed through well-designed random clinical trials.
Source: European Journal of Clinical Pharmacology - October 20, 2021 Category: Drugs & Pharmacology Source Type: research

Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis
Background: Direct oral anticoagulants (DOACs) have been increasingly preferred over warfarin; however, The International Society of Thrombosis and Hemostasis recommended avoiding the use of DOACs in morbidly obese patients (body mass index>40 or weight>120 kg) because of limited clinical data. Study Question: Are DOACs effective and safe in morbidly obese patients with nonvalvular atrial fibrillation (NVAF). Data Sources: We performed a comprehensive search for published studies indexed in PubMed/MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials that evaluated the efficacy and safet...
Source: American Journal of Therapeutics - September 1, 2021 Category: Drugs & Pharmacology Tags: Meta-analysis Source Type: research

A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease
CONCLUSIONS: If OACs for stroke prevention with AF are deemed necessary, apixaban or rivaroxaban can be considered. DOACs cannot currently be recommended over warfarin in patients with CKD-5 or ESKD and VTE.PMID:34459281 | DOI:10.1177/10600280211040093
Source: The Annals of Pharmacotherapy - August 30, 2021 Category: Drugs & Pharmacology Authors: Jessica A Starr Nathan A Pinner Melanie Mannis Mary Katherine Stuart Source Type: research